glp-1 inflammation reduction Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Weight Reduction with GLP-1 Agonists
Description
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus
10.1016/j.nano.2016.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar] 19.Melgar S, Karlsson L, Rehnstrm E, Karlsson A, Utkovic H, Jansson L, Michalsson E
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, active pancreatitis, severe diabetic retinopathy, and certain pregnancy circumstances
In fact, according to the CDC, New Jersey is #7 among the 50 states when ranked by which ones have the lowest prevalence of obesity
